{"name":"Retina Consultants of Orange County","slug":"retina-consultants-of-orange-county","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxNS1pXS2lqVzQxaHhpc1pEZmY1NmJCOGhEUlJrOFoxcHVBMXNRVTFLdkZXbjFxVS1wTk9tRlUyakFFSi1QQk44TERaMnUtZDZLbFNQYl9tbkFrX3d4Qjl1V19OelYzLU1iMjRZWjFnQTZWUU9ta1JHNVlQS1kzTDZNamJCRVBoMVJLT2JodlV1T2JYVXBoRkxWcjlaQUpoS2xEUmhPRE91Rll6S0VWUWJ4V1k2UFg4eHI3ZWJONjg5M0hEWURsUGdjcTFRX1drR2ZuZEtFZlRqcUYxdHVQcHNLUFJHVllhTzh6S0N0Si04QUJwc3B0SU1vMVI1eUtQbFJrLXNiOENyWmIwcDIyTmZPM0RQSjM3OU9ucGxsN0c4MnR1elpUcjFaMWtTOFdySE5RTFZpY3d4WlphZnY0T29jZ1cyUEJocmpmd2hVU3ZR?oc=5","date":"2025-10-09","type":"trial","source":"GlobeNewswire","summary":"Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando - GlobeNewswire","headline":"Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdVNUQWlKbExGT0ZHTVgtbExHYmw1dGtSdHU1cjN2Ymw5ME1QcnNRTkFWeFZSaEl4VkdnV3NKVlE0bFVhRVEwVE9fenZoQmJJbEZPUXlLb1hBTnhjVWlJTHZKa18wUGE3T3VNUnh5UUpfd3p4Y2NkZ2huajVySWFPX3lsSzZJV1RwelJqekIxRE5FSEpSb0tmM3dORmRxQjc3aXBhQmk0S0U?oc=5","date":"2025-06-03","type":"pipeline","source":"Healio","summary":"When should patients be referred to retina specialists? - Healio","headline":"When should patients be referred to retina specialists?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNVURVS05XcmlSUmYta3RTcmw5S0FHUWZuZV9GanRpOVI2MHhzd0ZROWtYOXVWQks4ODZmMTBzM2c2ZTRPLUxTTEpSamN0Mjl3TWlfY3RWMUhOZWtPZHpsclotQzJ4MFlZSHg3R2FVc0tjd2VTNTFXVXVLZjRiQlNrc202Z082UmlCZFFPWXRoQnhWMW1QOVRzSHFvaDhFZ0E4ZFdZSzBteE00eUpvWEhNcWlWTHZleVREVVBobEoyNm13MnlLNUQycV9Cb3VrQnRZLTBKbTBlYlktRTVVTEEyb1FybkFGOVBINWpBSFdEZ2FYel9xQmln?oc=5","date":"2025-03-04","type":"trial","source":"Ophthalmology Times","summary":"Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD - Ophthalmology Times","headline":"Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with w","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}